Market Tracker

10/24 6:05pm ET

Merck & Co Inc (NYSE:MRK)

57.61
Data as of Oct 24
 +0.98 / +1.73%
Today’s Change
44.62
Today|||52-Week Range
61.33
+15.10%
Year-to-Date
Profit From the Longer Life Spans, Part 1
12:22pm / TheStreet.com
Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
Oct 20 / Zacks.com
Trade-Ideas: Merck (MRK) Is Today's Post-Market Leader Stock
Oct 24 / TheStreet.com
3 Stocks Reiterated As A Buy: INTC, MRK, JNJ
Oct 20 / TheStreet.com
Will Merck (MRK) Pull a Surprise this Earnings Season? - Analyst Blog
Oct 24 / Zacks.com
Dow Jones (DJIA) Today: Merck (MRK) Higher
Oct 20 / TheStreet.com
Fast Money Halftime Report Final Trade From October 24
Oct 24 / Benzinga
US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteu...
Oct 20 / Benzinga
Q3 Earnings: Weak Growth & Guidance - Earnings Preview
Oct 24 / Zacks.com
This Drug Could Outsell Medical Marijuana
Oct 19 / MotleyFool.com
Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street
Oct 24 / MotleyFool.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Eli Lilly/Boehringer's Diabetes Drug Under FDA Review - Analyst Blog
Oct 23 / Zacks.com
3 Small-Cap Biotech Stocks to Buy if the Market Crashes
Oct 15 / MotleyFool.com
Video: Looking For Investing Opportunities Around The World
Oct 23 / StockTwits
Johnson & Johnson and Bristol-Myers Squibbbs New Collaboration Just the Tip of the Ic...
Oct 15 / MotleyFool.com
Fast Money Picks For October 23
Oct 23 / Benzinga
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Oct 14 / MotleyFool.com
Drug ETFs Attractive Buys On Pullback
Oct 22 / Benzinga
A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
Oct 13 / MotleyFool.com
3 Drugs Stocks Pushing The Industry Higher
Oct 22 / TheStreet.com
Fortune 500 companies spend more than $15bn on corporate responsibility
Oct 12 / FT.com
Regulus Gets Seat at Hep C Table With Today's Impressive Drug Results
Oct 22 / TheStreet.com
Merck sale boosts Europe's corporate bond market
Oct 06 / FT.com
Speculating on Achillion's Boom-or-Bust Hep C Drug Study Results
Oct 22 / TheStreet.com
As Ebola spreads, drug stocks surge
Oct 01 / CNNMoney.com